Best in Biotech 12 Apr 2023 6 new vaccines being developed for difficult-to-treat diseases …Application (BLA) to the FDA, and Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) in 2025. HER2 DNA study: Vaccine for breast cancer There is a lot of… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 11 Dec 2017 New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients …before releasing PBD which binds DNA that forms cross-links between the two DNA strands to block cell division. Importantly, PBD dimers do not distort the DNA structure, which helps them… December 11, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 17 Feb 2023 Immuno Cure starts HIV drug trial Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park, which specializes in PD-1-enhanced DNA vaccines and immunotherapies, has started its phase I clinical trial… February 17, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 17 Jul 2017 Israeli Biotech Partners with German Chem Giant to Develop Non-GMO Herbicide Resistance …own DNA, without the need of introducing external genes. In order to leverage this technology, the company has partnered with the giant chemical company BASF to discover new herbicide resistance… July 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Sep 2018 10 Biotech Companies in Berlin You Should Know …a DNA molecule that can influence the activity of the immune system. The candidate drug is currently in Phase III trials for treating metastatic colorectal cancer and in Phase II… September 10, 2018 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Apr 2019 The 8 Best Biotech Companies in Europe’s History …the time and money necessary to sequence DNA, was invented by researchers at Cambridge University and turned into reality by CEO Nick McCooke. “I came out with the slogan of… April 2, 2019 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 9 Nov 2020 Gene Drives: A Controversial Tool to Fight Malaria …in 2003 by Austin Burt, a professor at Imperial College London. Burt was studying ‘selfish genes’ that can copy themselves into a specific target DNA sequence. He suggested that these… November 9, 2020 - 12 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2018 Here’s Another Reason to Eat Plenty of Fruit and Vegetables …The molecules manage this by turning off an enzyme called histone deacetylase 2 (HDAC2), which modifies the packaging of DNA, making it less easy to access for the transcription machinery…. January 11, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 8 Aug 2022 Epigenic Therapeutics raises $20M for gene editing technology …gene(s) at once without changing the sequence of the DNA. The company said its platform is capable of overcoming the potential risk rising from DNA cleavage including but not limited… August 8, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Mar 2023 5 female-led biotech startups making waves …genetic material, C3DNA allows for large gene cargoes, as well as the expression of multiple genes. Another possible advantage is that, because C3DNA doesn’t have a protein coat, the body… March 8, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 27 May 2017 “Trust me, I’m an Artist” Explores the Ethics of Biotech in Amsterdam …which carry the girls’ DNA, raise questions about identity and highlight ethical concerns over the ownership of biological materials when the donors are minors. As their mother, Czarnecki consented for… May 27, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 5 Feb 2025 Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients …signed a partnership agreement last year with Scancell to develop a needle-free DNA vaccine for advanced melanoma using PharmaJet’s delivery system, which had already shown effective uptake of the DNA… February 5, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email